accacc2022acc2023acc2024acuteaddressingadjuvantadultsadvancedahaanalysisartarthritisasco2021ashash2023ash2024asthmaatrialbasedbccbenefitbenefitsbetabetterbladderbloodbreakingbreastcancercarcinomacardiaccardiologycardiovascularcarecellchallengeschemotherapychest2024chronicclinicalcllcombinationcontroversiescopdcoronarycovidcurrentdailydatadiabetesdiagnosisdiseasediseasesdosedrugsearlyeasd2022eaueffectefficacyehaeha2025ersers2024escesc2021esc2022esc2023esc2024eshesh2022esh2023esh2024esmoesmo2021esmo2023esmo2024eulareular2024eventsevidencefailurefibrillationfirstfocusfreefuturegallenglpguidelineguidelineshealthhearther2hfpefhighhighlightshrhypertensionimmuneimmunotherapyimpactimproveimprovesinhibitorsinsightsinterstitialinterviewisth2022iwlhjointkeykeynotekidneylandscapelargelateleukemialifelipidlongloweringlunglymphocyticlymphomamanagementmanagingmelanomametastaticmultiplemyeloidmyelomanavigatingnextnovelnoveltiesobesityolderoptionsoutcomesoverallparadigmpatientpatientspembrolizumabpeoplephasepluspositivepostpracticepressurepreventionprimaryprogressionprostatepulmonaryrandomizedrealreceptorrecurrencerefractoryrelatedrenalrespiratoryresultsriskrolesabcs2024safetyscreeningsevereshowsstagestandardstatestrategiesstudysurgerysurvivalsyndromesyndromessystemictargetedtermtherapeutictherapiestherapytreatmenttrialtrialstripleupdateupdatesvaccineversuswcclworldwvcdc